ASSET PURCHASE AGREEMENT (Tables)

12 Months Ended

Sep. 30, 2023

ASSET PURCHASE AGREEMENT

Schedule of consideration paid for asset acquisition

Cash	$	625,000
750,000 Company shares at $1.27/share (share price on July 12, 2023)		952,500
Direct transaction costs		437,360
Total consideration paid for acquiring Spindle RNAP enzyme platform	$	2,014,860